Features of Canadian Biotech Innovative Firms: Results from the Biotechnology Use and Development Survey - 2001 - ARCHIVED

Articles and reports: 88F0006X2003005


The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2001 Biotechnology Use and Development Survey. Within the last few years, except for the amount of financing capital raised, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 358 in 1999 to 375 in 2001. The Human Health sector outpaces all the other sectors in terms of the number of firms, human resources, biotechnology revenues, biotechnology research and development expenditures, amount of financing capital raised, and the number of products in the pipeline. Contrary to medium-sized and large firms where the personnel is more homogenous, small firms employ mostly highly-qualified workers. The 2001 data show a maturing trend in small firms. Most firms could not hire enough people to fill all their vacancies (estimated at 953 positions in Canada) for the 2001 year.

Issue Number: 2003005
FormatRelease dateMore information
PDFMarch 28, 2003

Related information

Source (Surveys and statistical programs)
Related products


Subjects and keywords



Date modified: